Day: December 22, 2025

Board seeks stockholder approval for flexible 1-for-5 to 1-for-50 range to help meet minimum bid price requirements and broaden investor access MARLBOROUGH, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) — ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses powering the modern energy economy, today announced that its Board of Directors has approved, and will be seeking stockholder approval for, an amendment to the Company’s Certificate of Incorporation to authorize a reverse split of the Company’s common stock at a ratio in the range of 1-for-5 to 1-for-50, with the exact ratio to be determined at a later date by the Board in its sole discretion. Aligning Capital Markets Profile with Uplisting Plans “Over the last year, we have focused on strengthening our balance...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and survival in SOD1-ALS Over 3 years, a subset of QALSODY-treated participants regained previously lost function and strength, something not previously reported in the natural history of SOD1-ALS Biogen is committed to advancing additional ALS research, including the ongoing QALSODY ATLAS study in pre-symptomatic SOD1-ALS and a robust discovery pipeline in ALSCAMBRIDGE, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) – today announced that The Journal of the American Medical Association (JAMA) Neurology has published final results from the completed Phase 3 VALOR study and its open-label extension (OLE) study evaluating QALSODY® (tofersen) for the treatment of superoxide dismutase 1 (SOD1)...

TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders of progress by Albright Metals Limited (ABR-ASX) formerly called Bryah Resources Ltd. at the Golden Pike Gold and Antimony property in New Brunswick under option from Globex (see Globex press release dated May 22, 2025 for transaction terms by clicking here). Albright reports that it has “completed an infill and extensional drilling program at its Vail Road High Grade Gold deposit. Approximately 990 metres of oriented HQ diamond drill core has been acquired from 15 drill holes, with target zones intercepted...

Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company”) announces repricing of the Incentive Options granted as of December 12, 2025. Please see Sparton News Release dated December 12, 2025. New Incentive Options Repricing The company has awarded and approved effective December 12, 2025, the issuance of 4,200,000 incentive options to Directors, Officers, and Consultants. These options are vested immediately and entitle the holder to purchase one common share of the Company at the new price of $0.05 per share from the effective date for 3 years, or until December 12rd, 2028. These have been repriced based on the TSXV Market Price Definition under Policy 1.1 up to Policy 4.4.   The old...

Schindellegi, Switzerland – 22 December 2025 Trifork Group AGCompany announcement no. 58/2025European Regulatory News Initiation of share buyback program Today, Trifork Group AG (“Trifork”) announces that the Board of Directors has decided to initiate a share buyback program of up to DKK 14.92 million (approximately EUR 2.0 million). The share buyback program is initiated pursuant to the decision of the Board of Directors taken on 22 December 2025 to acquire own registered shares with a nominal value of CHF 0.10 each. The purpose of the program is to meet Trifork’s obligations pursuant to the employee stock program and potentially to reduce the share capital by cancellation of shares, if and to the extent so decided in the future by the Board of Directors, by use of the new capital band set forth in the articles of association of...

VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo Silver” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a non-brokered private placement offering of 5,000,000 units (the “Units”) of the Company at a price of $5.00 per Unit, for aggregate gross proceeds of $25,000,000 (the “Offering”), Eric Sprott and a fund managed by Jupiter Asset Management (the “Jupiter Fund”), Apollo Silver’s two largest shareholders are participating in the Offering. Mr. Sprott and the Jupiter Fund each will subscribe for 2,500,000 Units of the Company, for combined gross proceeds of $25 million. Following completion of the Offering, the Jupiter Fund will own approximately 12.1% of Apollo Silver’s issued and outstanding common shares, while Eric Sprott will own approximately 9.6%,...

– Halneuron® treated patients separating from placebo on pain improvement assessment; Company expects top-line results availability in Q3 2026 – – The overall study dropout rate of ~4.4% is far below rates typically observed with other FDA approved chronic pain medicines – ATLANTA, Dec. 22, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines to treat pain and neuropathy, today announces positive results from an interim analysis of 97 patients who had completed treatment in the ongoing Halneuron® Phase 2b chemotherapy induced neuropathic pain (“CINP”) study. The independent statistical review committee reviewed unblinded patient treatment data from the Phase 2b trial and concluded that Halneuron® treated patients...

2026 financial calendar for ALK (ALKB:DC / OMX: ALK B):23 January 2026:                      Silent period                        20 February 2026:                    Annual report 2025              16 March 2026 at 4.00 p.m.:     Annual General MeetingWritten requests to have specific business transacted at the AGM will be included in theagenda if received by the company on30 January 2026 at the latest(may be emailed to investor@alk.net)7 April 2026:                             Silent period                        5 May 2026:                             Three-month interim report (Q1) 2026              23 July 2026:                            Silent period                        20 August 2026:                       Six-month interim report (Q2) 2026                  21 October 2026:                      Silent period                        18...